Skip to main content

ibr 280 (Imbruvica 280 mg)

Generic Name: ibrutinib

Pill with imprint ibr 280 is Purple, Elliptical/Oval and has been identified as Imbruvica 280 mg. It is supplied by Pharmacyclics, Inc.

Imbruvica is used in the treatment of chronic lymphocytic leukemia; waldenström macroglobulinemia; mantle cell lymphoma; non-hodgkin's lymphoma; lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 280 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ibr 280

Imbruvica 280 mg ibr 280

Imbruvica

Generic Name
ibrutinib
Imprint
ibr 280
Strength
280 mg
Color
Purple
Size
15.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
BTK inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pharmacyclics, Inc.
National Drug Code (NDC)
57962-0280

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.